HotSpot Therapeutics
Andover, Massachusetts, United States
Disclosure information not submitted.
Targeting IRF5: Discovery and Preclinical Development of Selective Small Molecule Inhibitors
Wednesday, June 25, 2025
4:00pm - 4:15pm East Coast USA Time
